Promotions & Discounts

  • Free 2 x 100ul aliquots of Virovek's AAV control vectors for all new customers! More

  • Special offer for all academic and non-profit organizations on Virovek's custom-made AAV vectors. More

  • Technology Licensing Opportunity

    Virovek has developed the world’s most robust and efficient large-scale AAV vector production platform [US Patent No. 8,945,918 B2 (issued February 3, 2015)]. This production technology has been further developed to produce at normal levels of AAV vectors carrying toxic genes for cancer therapy [US Patent No. 9,175,312 B2 (issued November 3, 2015)].

    There is no longer a bottleneck in AAV production whether the AAV carries a non-toxic or a toxic gene as a result of our proprietary technologies. Combining the multi-fold scientific development and processing advancements in the field of gene therapy with Virovek’s scalable AAV production system, using AAV as a therapeutic vehicle for a broad range of diseases is now a reality.

    Please contact us for a non-exclusive licensing opportunity.

    Leave a Reply

    You can use these HTML tags

    <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>